High-Grade Atrioventricular Block and Recurrent Cardiac Arrest in Suspected Isolated Cardiac Sarcoidosis
Related Experiment Video
Updated: Oct 24, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
AbdulRahman Masaud Talib1, Shatha Alalawi1, Yousef M Abozinadah2
1Department of Cardiology, King Abdullah Medical Complex, Jeddah, Saudi Arabia.
Background:
Cardiac sarcoidosis may cause advanced atrioventricular block, ventricular dysfunction, and sudden cardiac death. Isolated cardiac presentations are diagnostically challenging when histologic confirmation and fluorodeoxyglucose positron emission tomography are unavailable.
Case Summary:
An 18-year-old woman with recurrent syncope developed high-grade atrioventricular block and recurrent brady-asystolic cardiac arrest requiring temporary transvenous pacing. Echocardiography showed severe left ventricular dysfunction. Cardiac magnetic resonance demonstrated regional septal thickening, basal to midseptal midmyocardial late gadolinium enhancement and a left ventricular ejection fraction of 38.9%. No extracardiac sarcoid pattern or biopsy target was identified. Giant cell myocarditis and inherited cardiomyopathy remained important alternative diagnoses. She received corticosteroid therapy and subsequently underwent cardiac resynchronization therapy-defibrillator implantation.
Conclusion:
Cardiac sarcoidosis should remain a diagnostic consideration in young patients with malignant conduction disease and inflammatory cardiomyopathy, while important mimics must be actively considered.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
